VanEck Biotech ETF
BBH
111 hedge funds and large institutions have $125M invested in VanEck Biotech ETF in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 14 closing their positions.
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
15% more capital invested
Capital invested by funds: $109M → $125M (+$16.5M)
5% more funds holding
Funds holding: 106 → 111 (+5)
3.26% more ownership
Funds ownership: 29.97% → 33.22% (+3.3%)
14% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 28
67% less call options, than puts
Call options by funds: $757K | Put options by funds: $2.29M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$5.06M |
| 2 |
LPL Financial
San Diego,
California
|
+$2.29M |
| 3 |
Two Sigma Investments
New York
|
+$2.18M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$1.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$651K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
-$7.74M |
| 2 |
BRM
Boston Research & Management
Manchester,
Massachusetts
|
-$1.73M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.51M |
| 4 |
Goldman Sachs
New York
|
-$1.34M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$473K |
BBH Hedge Fund Activity: Q4 2025 in Review
111 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2025, worth a combined $125M — up 15% from $109M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new BBH positions and 14 closed out — a net gain of 6 holders — while 24 added to existing stakes and 28 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $5.06M. The largest seller was Miller Investment Management, cutting an estimated $7.74M.
- 111 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2025, up from 106 in Q3 2025.
- Funds reported $125M of VanEck Biotech ETF stock for Q4 2025, up 15% quarter-over-quarter.
- 20 funds opened new VanEck Biotech ETF positions in Q4 2025 and 14 closed out, a net change of +6 holders.
- The largest VanEck Biotech ETF buyer in Q4 2025 was Morgan Stanley, an estimated $5.06M added.
- The largest VanEck Biotech ETF seller in Q4 2025 was Miller Investment Management, an estimated $7.74M sold.
Based on aggregated 13F filings for Q4 2025.